JPMorgan Chase & Co. news

   Watch this stock
Showing stories 11 - 20 of about 163   

Articles published

JPM 62.13 +0.16 (0.26%)
price chart
Euronav NV Earns Overweight Rating from Analysts at JPMorgan Chase & Co ...
Euronav NV logo JPMorgan Chase & Co. initiated coverage on shares of Euronav NV (NASDAQ:EURN) in a research note released on Monday morning, TheFlyOnTheWall.
Caixabank Downgraded by JPMorgan Chase & Co. (CAIXY)  Intercooler
Petrobras Scandal News: Oil Company Reportedly Hires JPMorganChase & Co ...
Brazil's state-controlled oil producer, Petr�leo Brasileiro SA, commonly known as Petrobas, has hired JPMorgan to handle $3 billion in planned asset sales this year.
JPMorgan Chase & Co. Sticks To Anti-Splitting Stance
Many analysts have suggested JPMorgan Chase & Co. (NYSE:JPM) to split up into smaller entities, as the bank faces increased scrutiny due to its size and complexity.
Prudential Public Limited Company's Neutral Rating Reaffirmed at JPMorgan ...
Also, JPMorgan Chase & Co. reiterated its neutral rating on shares of Standard Chartered PLC. They have a GBX 1,050 ($16.18) price target on that stock.
JPMorgan Chase & Co. Announces 1 Million Plus Apple Inc. Pay Users
JPMorgan Chase & Co. (NYSE:JPM) had its 2015 Investors Day on Tuesday, where it announced that over a million customers are making transactions with their credit and debit cards through Apple Pay.
JPMorgan Chase & Co. Boosts Berendsen PLC Price Target to GBX 1180 (BRSN)
Berendsen PLC logo Berendsen PLC (LON:BRSN) had its price target upped by JPMorgan Chase & Co. from GBX 1,113 ($17.15) to GBX 1,180 ($18.18) in a research note issued to investors on Monday.
JPMorgan Chase & Co. Reiterates "Overweight" Rating for ...  The Legacy
Senior plc Rating Reiterated by JPMorgan Chase & Co. (SNR)  sleekmoney
JPMorgan Chase & Co. Lowers PTC Therapeutics to Neutral (PTCT)
JPMorgan Chase & Co. cut shares of PTC Therapeutics (NASDAQ:PTCT) from an overweight rating to a neutral rating in a research note issued to investors on Monday, TheFlyOnTheWall.
PTC Therapeutics Downgraded by JPMorgan Chase & Co. to "Neutral ...  sleekmoney
JPMorgan Chase & Co. Downgrades PTC Therapeutics to Neutral (PTCT)  Dakota Financial News
JPMorgan Chase & Co. Raises CoStar Group Price Target to $208.00 (CSGP)
CoStar Group Inc logo CoStar Group (NASDAQ:CSGP) had its price target increased by JPMorgan Chase & Co. from $195.00 to $208.00 in a research report sent to investors on Friday morning.
CoStar Group CFO Brian J. Radecki Sells 14634 Shares (CSGP)  WKRB News
JPMorgan Chase & Co. Reaffirms "Neutral" Rating for Capita PLC (CPI)
JPMorgan Chase & Co. reaffirmed their neutral rating on shares of Capita PLC (LON:CPI) in a report released on Friday. JPMorgan Chase & Co. currently has a GBX 1,180 ($18.18) price objective on the stock. JPMorgan Chase & Co. has also modified their ...
Senior plc Given "Overweight" Rating at JPMorgan Chase & Co. (SNR)
Senior plc logo Senior plc (LON:SNR)'s stock had its �overweight� rating reissued by equities research analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday. They currently have a GBX 400 ($6.16) price target on the stock.